Refusing to slow down since the start of the new year, shares of Tempus AI (NASDAQ: TEM) have skyrocketed nearly 99% since ...

We recently published an article titled Top 10 Health Information Services Stocks Outpacing The Market In 2025. In this ...

We recently published a list of 10 Firms Post Double-Digit Gains on Thursday. In this article, we are going to take a look at ...

We recently compiled a list of the 10 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...

Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) in ...

Shareholders in Tempus AI, Inc. ( NASDAQ:TEM ) may be thrilled to learn that the analysts have just delivered a ...

We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Selling Recently. In this article, we are going to take a ...

Sabre (NASDAQ:SABR – Get Free Report) and Tempus AI (NASDAQ:TEM – Get Free Report) are both computer and technology companies, but which is the superior stock? We will contrast the two businesses ...

William Blair downgraded Tempus AI Inc (NASDAQ:TEM) to "Market Perform" from "Outperform" given stock's sharp rally rather than any concerns over the company’s fundamentals. Tempus shares have surged ...

IFLI is committed to supporting advances in understanding the biology of FL patients who are at high risk of cancer progression and enhancing therapeutic development to address critical unmet needs in ...

TD Cowen reaffirmed their buy rating on shares of Tempus AI (NASDAQ:TEM – Free Report) in a research note published on Wednesday, Marketbeat Ratings reports. TD Cowen currently has a $74.00 price ...

Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced they will report financial results for the fourth quarter and full year 2024 on Monday, ...